Which is the Better Choice for Healthcare Investors? IYH or BBH?
BBH delivered 33.6% returns but swung 39.9% lower; IYH's 100 holdings offer steadier performance with 1.2% dividend yield.
Overview
Investors choosing between iShares U.S. Healthcare ETF (NYSEMKT:IYH) and VanEck Biotech ETF (NASDAQ:BBH) may weigh the broader, lower-volatility healthcare exposure of IYH against the concentrated, high-growth biotechnology focus of BBH.
Investors choosing between the biotechnology subsector and the broader healthcare industry often weigh high growth potential against portfolio stability. While BBH focuses on 25 biotech firms, IYH includes 100 companies, like pharmaceutical giants and equipment makers. This comparison examines how these different strategies impact costs, risks, and yields.
Details
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
Source
Originally published at www.fool.com.